• Tuesday,October 01,2024
ururembotoursandtravel.com
X

New strategy for COVID-19 vaccination: targeting the receptor

$ 16.00

4.9 (541) In stock

Share

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a

News & Comment Cellular & Molecular Immunology

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment

COVID-19: Coronavirus replication, pathogenesis, and therapeutic

The commonly available platforms and mechanisms for cancer vaccine

Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein - ScienceDirect

Vaccination strategies and Therapeutic monoclonal antibodies (mAbs

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach

Respiratory mucosal delivery of next-generation COVID-19 vaccine

Viral targets for vaccines against COVID-19

Strategies to Support Ontarians' Capability, Opportunity, and

Junzhi Wang's research works National Institutes for Food and Drug Control, China, Beijing (NIFDC) and other places